BridgeBio Pharma, Inc. (BBIO) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading BBIO…

BridgeBio Pharma, Inc. (BBIO) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

BridgeBio Pharma, Inc.

BBIO · CIK 1743881

4 · Sep 21, 2026 · Director, Chief Executive Officer Kumar Neil sold 10K shares at $69.08/share ($690.8K)

4

Director, Chief Executive Officer Kumar Neil sold 10K shares at $69.08/share ($690.8K)

Filed: Sep 21, 2026
Period: Sep 17, 2026
Accession: 0001470831-26-000897
Filer: BridgeBio Pharma, Inc.

View on SEC.gov All SEC filings

Filing document

FORM 4

xslF345X06/wk-form4_1790029286.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4FORM 4wk-form4_1790029286.xml
Open SEC.gov